| 2025 | ||||||||||||||||||||||||||||||||||||||||||||
| <<MAY | JUN | JUL>> | ||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||
US-India BioPharma Summit
Summit theme: Delivering Affordable Innovation through Cross Border Partnerships
Keynote addresses:
Honorable Kapil Sibal, Minister of Science & Technology, Government of India*
Dr. M.K. Bhan, Secretary, Department of Biotechnology*
Dr. Surinder Singh, Drug Controller General of India*
Discussions covering:
1. Drug Discovery, Development, Clinical Trials, In/Out Licensing, IP and Regulatory Issues
2. Funding Innovation, Cross Border Investments, Investment Opportunities and M&A trends in the US-India Bio Pharma industry
Cocktails & Networking Reception
Date: 06/13/2008
Location: President’s Ballroom, Hyatt Regency, Cambridge, Massachusetts
Time: 2:00 pm - 8:30 pm
Cost: $500
Web: www.usaindiachamber.org